RadNet, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
RadNet, Inc. (RDNT) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$45.97 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-09
- RadNet, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$12.00M.
- RadNet, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$33.97M.
- RadNet, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $55.13M, a 38.90% increase year-over-year.
- RadNet, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$12.48M, a 155.56% decline year-over-year.
- RadNet, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$3.90M.
- RadNet, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$3.96M.
- RadNet, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$668.00K.
- RadNet, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$1.94M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|
| 2017-06-30 | -$12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$45.97M 10-Q · filed 2017-08-09 | $9.16M derived: sum of 3 quarters · filed 2017-08-09 | -$3.32M derived: sum of 4 quarters · filed 2017-08-09 | |
| 2017-03-31 | -$33.97M 10-Q · filed 2017-05-10 | $21.16M derived: sum of 2 quarters · filed 2017-05-10 | $8.68M derived: sum of 3 quarters · filed 2017-05-10 | -$10.06M derived: sum of 4 quarters · filed 2017-08-09 | |
| 2016-12-31 | $55.13M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-03-31 | $42.65M derived: sum of 2 quarters · filed 2017-03-31 | $23.90M derived: sum of 3 quarters · filed 2017-08-09 | -$3.90M 10-K/A · filed 2017-03-31 | -$65.49M 10-K · filed 2017-03-17 |
| 2016-09-30 | -$12.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$31.23M derived: sum of 2 quarters · filed 2017-08-09 | -$59.03M 10-Q · filed 2016-11-09 | -$19.34M derived: sum of 4 quarters · filed 2017-08-09 | |
| 2016-06-30 | -$18.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$46.55M 10-Q · filed 2017-08-09 | -$6.86M derived: sum of 3 quarters · filed 2017-08-09 | $15.61M derived: sum of 4 quarters · filed 2017-08-09 | |
| 2016-03-31 | -$27.80M 10-Q · filed 2017-05-10 | $11.89M derived: sum of 2 quarters · filed 2017-05-10 | $34.36M derived: sum of 3 quarters · filed 2017-05-10 | -$12.14M derived: sum of 4 quarters · filed 2017-05-10 | |
| 2015-12-31 | $39.69M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-03-31 | $62.16M derived: sum of 2 quarters · filed 2017-03-31 | $15.66M derived: sum of 3 quarters · filed 2017-03-31 | -$3.96M 10-K/A · filed 2017-03-31 | -$96.80M 10-K · filed 2016-03-15 |
| 2015-09-30 | $22.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$24.03M derived: sum of 2 quarters · filed 2016-11-09 | -$43.65M 10-Q · filed 2016-11-09 | -$401.00K derived: sum of 4 quarters · filed 2017-03-31 | |
| 2015-06-30 | -$46.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$66.12M 10-Q · filed 2016-08-09 | -$22.87M derived: sum of 3 quarters · filed 2017-03-31 | -$37.28M derived: sum of 4 quarters · filed 2017-03-31 | |
| 2015-03-31 | -$19.62M 10-Q · filed 2016-05-10 | $23.63M derived: sum of 2 quarters · filed 2017-03-31 | $9.22M derived: sum of 3 quarters · filed 2017-03-31 | -$2.10M derived: sum of 4 quarters · filed 2017-03-31 | |
| 2014-12-31 | $43.25M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-03-31 | $28.84M derived: sum of 2 quarters · filed 2017-03-31 | $17.52M derived: sum of 3 quarters · filed 2017-03-31 | -$668.00K 10-K/A · filed 2017-03-31 | -$53.64M 10-K · filed 2015-03-16 |
| 2014-09-30 | -$14.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$25.72M derived: sum of 2 quarters · filed 2015-11-09 | -$43.91M 10-Q · filed 2015-11-09 | -$5.28M derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-06-30 | -$11.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$29.50M 10-Q · filed 2015-08-10 | $9.13M derived: sum of 3 quarters · filed 2016-03-30 | -$4.73M derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-03-31 | -$18.19M 10-Q · filed 2015-05-11 | $20.45M derived: sum of 2 quarters · filed 2016-03-30 | $6.58M derived: sum of 3 quarters · filed 2016-03-30 | -$5.76M derived: sum of 4 quarters · filed 2016-03-30 | |
| 2013-12-31 | $38.64M derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-03-30 | $24.78M derived: sum of 2 quarters · filed 2016-03-30 | $12.43M derived: sum of 3 quarters · filed 2016-03-30 | -$1.94M 10-K/A · filed 2016-03-30 | -$50.66M 10-K · filed 2014-03-17 |
| 2013-09-30 | -$13.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$26.21M derived: sum of 2 quarters · filed 2014-11-10 | -$40.57M 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | -$12.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$26.71M 10-Q · filed 2014-08-11 | |||
| 2013-03-31 | -$14.37M 10-Q · filed 2014-05-12 | ||||
| 2012-12-31 | -$3.99M 10-K · filed 2015-03-31 | -$87.05M 10-K · filed 2014-03-17 | |||
| 2011-12-31 | -$2.58M 10-K/A · filed 2014-03-31 | -$87.74M 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |